Cancer diagnostics News and Research

RSS

New guidance recommends systematic use of 'exercise prescription' for cancer patients

A global panel of exercise oncology experts today published new guidance recommending the systematic use of an “exercise prescription” to help cancer patients cope with treatment side effects and lower the risk of developing certain cancers.

15 Oct 2019

Overweight before age 40 linked to increased cancer risk

In an international study, lead by the University of Bergen in Norway, the researchers wanted to find out how adult overweight (BMI over 25) and obesity (BMI over 30) increase the risk of different types of cancer.

11 Oct 2019

New blood test could help hasten the diagnosis of brain tumors

A blood test which could help to accelerate the diagnosis of brain cancer has been developed in research led at the University of Strathclyde.

9 Oct 2019

Osaka University Hospital begins clinical research for prostate cancer diagnosis using PET imaging

Osaka University Hospital began Japan's first clinical research for diagnosis of prostate cancer using PET (positron emission tomography) scan results in September 2019.

7 Oct 2019

Women under 40 often choose aggressive surgery out of fear of second breast cancer

Yes, it's not common. Breast cancer among women under 40 is rare. No matter the age, a cancer diagnosis causes anxiety and fear. In addition, women in their 20s and 30s face some unique challenges and daunting decisions. Deciding what type of surgery to have is one of them.

3 Oct 2019

Multi-gene testing at point of diagnosis can save all women with breast cancer

A lifetime model evaluating the financial, health and social impact of multi-gene testing (BRCA1/2/PALB2) at diagnosis for all breast cancer patients was found to be extremely cost effective for both UK and US health systems.

3 Oct 2019

New imaging technology may help surgeons better detect cancer during surgery

University of Texas at Dallas researchers have demonstrated that imaging technology used to map the universe shows promise for more accurately and quickly identifying cancer cells in the operating room.

30 Sep 2019

Study shows miRNAs in semen as non-invasive biomarkers for prostate cancer

Researchers of the Human Molecular Genetics group at the Bellvitge Biomedical Research Institute, led by Dr. Sara Larriba, in collaboration with Dr. Francesc Vigués and Dr. Manel Castells of the Urology Service of Bellvitge University Hospital, show the usefulness of certain molecules, the miRNAs in semen, as non-invasive biomarkers for prostate cancer.

26 Sep 2019

Targeting cancer patients' mindsets could improve their health and well-being

A diagnosis of cancer can cause significant emotional burden for patients and their families. The turmoil may persist throughout treatment and even years into survivorship.

25 Sep 2019

New genetic test could help avoid unnecessary prostate cancer surgery

Men who develop prostate cancer could avoid having unnecessary surgery or radiotherapy thanks to a new, more precise genetic test which is being trialed in Leeds.

25 Sep 2019

Global survey highlights unmet need of women living with cancer

Merck, a leading science and technology company, today released the Supporting Women With Cancer report, presenting findings from a global survey of 4,585 women across 23 countries.

25 Sep 2019

Early palliative care linked to better survival in patients with advanced lung cancer

Early palliative care is associated with better survival in patients with advanced lung cancer, according to a study by VA Portland Health Care System and Oregon Health and Science University researchers.

19 Sep 2019

Cancer patients who miss an appointment more likely to die within 12 months of diagnosis

Cancer patients who miss an urgent referral appointment for their symptoms are 12% more likely to die within 12 months of diagnosis, a major new study has found.

12 Sep 2019

Novel technology makes biopsies less invasive and more informative

A team of researchers from the National University of Singapore has developed a novel technology that could sensitively and accurately detect and classify cancer cells, as well as determine the disease aggressiveness from the least invasive biopsies.

10 Sep 2019

Liquid biopsies provide complete picture of genetic alterations linked to cancer drug resistance

Many patients see their tumors shrink in response to a drug, only to have them come back with a vengeance as they evolve to fend off the treatment. Oncologists want to be able to quickly detect cancer drug resistance as it emerges in their patients and identify another drug the tumors will still respond to.

10 Sep 2019

New blood test could aid earlier and precise diagnosis of lung cancer

Lung cancer can be spotted earlier and diagnosed more precisely with the help of a blood test, a major study carried out in Scotland has found.

9 Sep 2019

Researchers develop new cocktail of drugs that shrink pancreatic tumors

Cancer is relentless and resilient. When a drug blocks a cancer cell's main survival pathway, the cell avoids the obstacle by taking different pathways or detours to save itself. This tactic is called "developing resistance," and it's one of the key challenges researchers face when seeking effective therapeutics to combat pancreatic ductal adenocarcinoma (PDA).

9 Sep 2019

IASLC highlights importance of tobacco cessation after cancer diagnosis

The International Association for the Study of Lung Cancer today used the platform of its largest international meeting to call attention to the importance of tobacco cessation after cancer diagnosis, and urged all physicians to screen cancer patients for tobacco use and recommend tobacco cessation.

8 Sep 2019

MicroRNA methylation may be useful biomarker for early cancer diagnosis

Levels of molecules associated with genetic function, such as microRNA, can be an important indicator of abnormal activity associated with cancer. However, little is known about how different molecules are altered in cancerous cells.

4 Sep 2019

Researchers receive $2.9 million to develop new low-cost cancer diagnostic platform

Researchers at the University of Notre Dame have received $2.9 million to develop a new diagnostic platform that could diagnose cancer in as little as three hours by using only one or two drops of blood.

28 Aug 2019